Compound 226
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)NCCCO)c1=O
- InChi:
InChI=1S/C25H21F3N6O3/c1-33-22-18(13-30-33)21-19(20(31-22)15-4-2-5-16(12-15)25(26,27)28)24(37)34(32-21)17-8-6-14(7-9-17)23(36)29-10-3-11-35/h2,4-9,12-13,32,35H,3,10-11H2,1H3,(H,29,36)
- InChiKey:
JOIUZRRTKNSOEM-UHFFFAOYSA-N
External links
168318271 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.01 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 510.16 g/mol | |||
HBA | 9 | |||
HBD | 3 | |||
HBA + HBD | 12 | |||
AlogP | 3.44 | |||
TPSA | 112.38 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4959 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4739 | Ispinesib | DB06188 | |
0.4718 | Riociguat | DB08931 | |
0.4712 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4703 | MK-0249 | DB11910 | |
0.4701 | ATX-914 | DB12673 | |
0.4625 | Tepotinib | DB15133 | |
0.4583 | Risdiplam | DB15305 | |
0.4570 | Vericiguat | DB15456 | |
0.4538 | Merestinib | DB12381 | |
0.4530 | Decoglurant | DB11923 | |
0.4523 | Dilmapimod | DB12140 | |
0.4487 | MK-0893 | DB12044 | |
0.4449 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4444 | Filgotinib | DB14845 |